Serial Number | 98476104 |
Word Mark | XAIRA |
Filing Date | Friday, March 29, 2024 |
Status | 692 - WITHDRAWN BEFORE PUBLICATION |
Status Date | Thursday, January 16, 2025 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Goods and Services | Pharmaceutical therapeutics and medical therapeutics for treating indications and co-morbidities underlying immune-mediated inflammatory diseases, namely, pharmaceutical preparations for treating immunological diseases, cardiometabolic diseases, infectious diseases, and oncological diseases |
Goods and Services | Pharmaceutical research and development services using artificial intelligence and machine learning; Scientific and medical research in the field of pharmaceutical development using artificial intelligence and machine learning; Research and development of technology in the field of pharmaceuticals; Development of pharmaceutical medicines; Drug development and discovery |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Friday, March 29, 2024 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 7 - Inactive - Insufficient fee received |
Class Status Date | Friday, March 29, 2024 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | XAIRA THERAPEUTICS, INC. |
Party Type | 11 - New Owner Before Publication |
Legal Entity Type | 03 - Corporation |
Address | SAN FRANCISCO, CA 94108 |
Party Name | Orion Medicines, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | San Francisco, CA 94108 |
Event Date | Event Description |
Saturday, March 30, 2024 | NEW APPLICATION ENTERED |
Thursday, June 20, 2024 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
Sunday, September 1, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Thursday, October 10, 2024 | NON-FINAL ACTION WRITTEN |
Thursday, October 10, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Thursday, October 10, 2024 | ASSIGNED TO EXAMINER |
Thursday, October 10, 2024 | NON-FINAL ACTION E-MAILED |
Tuesday, January 7, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Tuesday, January 7, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Tuesday, January 7, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Wednesday, January 8, 2025 | FINAL REFUSAL E-MAILED |
Wednesday, January 8, 2025 | NOTIFICATION OF FINAL REFUSAL EMAILED |
Wednesday, January 8, 2025 | FINAL REFUSAL WRITTEN |
Wednesday, January 15, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Wednesday, January 15, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Wednesday, January 15, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, January 15, 2025 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
Thursday, January 16, 2025 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |